257 related articles for article (PubMed ID: 31102336)
1. Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two-center study.
Ni W; Chen J; Xiao Z; Yu S; Zhang W; Zhou Z; Chen D; Feng Q; Chen X; Lin Y; Zhu K; Gao S; Xue Q; Mao Y; Cheng G; Sun K; Liu X; Fang D
Thorac Cancer; 2019 Jun; 10(6):1431-1440. PubMed ID: 31102336
[TBL] [Abstract][Full Text] [Related]
2. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
[TBL] [Abstract][Full Text] [Related]
3. Postoperative radiotherapy for the young-old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience.
Ding W; Yang M; Jiang W; Ge X; Sun X; Zhou B; Liu F; Jiang K; Shen F; Sun X
Medicine (Baltimore); 2020 Apr; 99(17):e19453. PubMed ID: 32332598
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy for patients with pathologic node-negative esophageal carcinoma: A population based propensity matching analysis.
Gao HJ; Shang XB; Gong L; Zhang HD; Ren P; Shi GD; Wei YC; Yu ZT
Thorac Cancer; 2020 Feb; 11(2):243-252. PubMed ID: 31828980
[TBL] [Abstract][Full Text] [Related]
5. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer.
Xu Y; Liu J; Du X; Sun X; Zheng Y; Chen J; Li B; Liu W; Jiang H; Mao W
Radiat Oncol; 2013 May; 8():116. PubMed ID: 23656920
[TBL] [Abstract][Full Text] [Related]
7. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
[TBL] [Abstract][Full Text] [Related]
8. Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: Analysis of surveillance, epidemiology, and end results database.
Yu J; Ouyang W; Li Y; Hu J; Xu Y; Wei Y; Liao Z; Liu Y; Zhang J; Xie C
Cancer Med; 2019 Jan; 8(1):21-27. PubMed ID: 30561117
[TBL] [Abstract][Full Text] [Related]
9. [The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma].
Ni WJ; Deng W; Xiao ZF; Zhou ZM; Wang X; Chen DF; Feng QF; Liang J; Lyu JM; Bi N; Deng L; Zhang T; Wang WQ; Xue Q; Gao SG; Mu JW; Mao YS; Wang DL; Zhao J; Gao YS; Huang JF; Tan FW; Zhao L; Lyu F; Zhang GC
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):295-302. PubMed ID: 31014056
[No Abstract] [Full Text] [Related]
10. The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma.
Wong AT; Shao M; Rineer J; Lee A; Schwartz D; Schreiber D
Ann Surg; 2017 Jun; 265(6):1146-1151. PubMed ID: 27280504
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of surgery plus postoperative radiotherapy or definitive radiotherapy in older patients with thoracic esophageal squamous cell cancer.
Jiang W; Sun X; Zhou B; Han C; Liu F; Zheng J; Sun X
J Cancer Res Ther; 2019; 15(4):849-856. PubMed ID: 31436242
[TBL] [Abstract][Full Text] [Related]
12. The survival impact of postoperative complications after curative resection in patients with esophageal squamous cell carcinoma: propensity score-matching analysis.
Yamamoto M; Shimokawa M; Yoshida D; Yamaguchi S; Ohta M; Egashira A; Ikebe M; Morita M; Toh Y
J Cancer Res Clin Oncol; 2020 May; 146(5):1351-1360. PubMed ID: 32185488
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
14. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
15. Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.
Li B; Hu H; Zhang Y; Zhang J; Miao L; Ma L; Luo X; Zhang Y; Ye T; Li H; Zhou J; Li Y; Shen L; Zhao K; Fan M; Zhu Z; Wang J; Xu J; Deng Y; Lu Q; Jia H; Cheng X; Li H; Zhang Y; Li C; Pan Y; Liu S; Hu H; Shao L; Sun Y; Xiang J; Chen H
Ann Surg; 2018 May; 267(5):826-832. PubMed ID: 28448385
[TBL] [Abstract][Full Text] [Related]
16. Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival Analysis.
Li K; Du K; Li C; He W; Lu S; Liu K; Wang C; Nie X; Han Y; Huang Y; Wang Q; Peng L; Leng X
Ann Surg Oncol; 2024 Jun; 31(6):3794-3802. PubMed ID: 38372864
[TBL] [Abstract][Full Text] [Related]
17. The role of postoperative adjuvant chemotherapy for lymph node-positive esophageal squamous cell carcinoma: a propensity score matching analysis.
Qin RQ; Wen YS; Wang WP; Xi KX; Yu XY; Zhang LJ
Med Oncol; 2016 Apr; 33(4):31. PubMed ID: 26922662
[TBL] [Abstract][Full Text] [Related]
18. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
[TBL] [Abstract][Full Text] [Related]
19. Survival risk prediction model for patients with pT
Qi Z; Hu Y; Qiu R; Li J; Li Y; He M; Wang Y
J Cardiothorac Surg; 2021 May; 16(1):121. PubMed ID: 33933129
[TBL] [Abstract][Full Text] [Related]
20. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
